pd 158780 and quinazolines

pd 158780 has been researched along with quinazolines in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bridges, AJ; Cody, DR; Denny, WA; Fry, DW; McMichael, A; Palmer, BD; Rewcastle, GW; Thompson, AM; Zhou, H	1

Other Studies

1 other study(ies) available for pd 158780 and quinazolines

Article	Year
Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. Journal of medicinal chemistry, 1996, Apr-26, Volume: 39, Issue:9 Topics: ErbB Receptors; Humans; Isomerism; Magnetic Resonance Spectroscopy; Phosphorylation; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured	1996

Article

Year

Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor.

Journal of medicinal chemistry, 1996, Apr-26, Volume: 39, Issue:9

Topics: ErbB Receptors; Humans; Isomerism; Magnetic Resonance Spectroscopy; Phosphorylation; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured

1996